Travere Therapeutics, Inc. · NASDAQ:TVTX
Perceptive Advisors LLC reported a 5.50% stake in Travere Therapeutics, Inc. (Schedule 13G)
Event Oct 6, 2025 · Filed Oct 14, 2025
Perceptive Advisors LLC reported a 5.50% stake in Travere Therapeutics, Inc., 4,895,615 shares, as a passive investor on Oct 6, 2025. Filed Oct 14, 2025 (Schedule 13G).
- Stake
- 5.50%
- Shares
- 4,895,615
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Perceptive Advisors LLC | 5.50% | 4,895,615 |
| Joseph Edelman | 5.50% | 4,895,615 |
| Perceptive Life Sciences Master Fund, Ltd. | 5.50% | 4,895,615 |
Source
Related
- Travere Therapeutics, Inc.
- Perceptive Advisors LLC
- Travere Therapeutics, Inc. shareholders
- Schedule 13G/A · Perceptive Advisors LLC · Feb 17, 2026
- Form 4 · Dube Eric M · Oct 19, 2026
- Form 4 · Heerma Peter · Sep 17, 2026
- Form 4 · Dube Eric M · Sep 17, 2026
- Form 4 · Rote William E. · Sep 17, 2026
- Form 4 · Inrig Jula · Sep 17, 2026